| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| J1745 |
Injection, infliximab, excludes biosimilar, 10 mg |
1,510 |
1,402 |
$7.46M |
| J3380 |
Injection, vedolizumab, intravenous, 1 mg |
845 |
659 |
$4.27M |
| 99601 |
|
16,875 |
10,263 |
$1.23M |
| Q5103 |
Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg |
464 |
401 |
$1.10M |
| Q5121 |
Injection, infliximab-axxq, biosimilar, (avsola), 10 mg |
253 |
231 |
$448K |
| 99602 |
Nursing care in home rn |
4,931 |
4,138 |
$294K |
| S9500 |
Home infusion therapy, antibiotic, antiviral, or antifungal therapy; once every 24 hours; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem |
1,376 |
431 |
$245K |
| S9379 |
Home infusion therapy, infusion therapy, not otherwise classified; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem |
5,052 |
4,461 |
$227K |
| A4222 |
Infusion supplies for external drug infusion pump, per cassette or bag (list drugs separately) |
1,189 |
165 |
$72K |
| A4221 |
Supplies for maintenance of non-insulin drug infusion catheter, per week (list drugs separately) |
2,076 |
1,498 |
$38K |
| S9359 |
Home infusion therapy, anti-tumor necrosis factor intravenous therapy; (e.g., infliximab); administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem |
643 |
604 |
$32K |
| S9502 |
Home infusion therapy, antibiotic, antiviral, or antifungal therapy; once every 8 hours, administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem |
42 |
12 |
$12K |